Finance

Beta
Lists
1760:TPE
Panion & BF Biotech Inc
NT$61.30
+0.16%
(+0.100) 1D
Jun 5, 1:30:22 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1760...
Open
NT$61.70
High
NT$61.90
Low
NT$60.80
Mkt. cap
5.26B
Avg. vol.
373.37K
Volume
262.15K
Dividend
3.26%
Quarterly dividend
NT$0.50
Ex-dividend date
Jun 11, 2026
P/E ratio
24.64
52-wk high
NT$82.00
52-wk low
NT$58.00
EPS
NT$2.49
Shares outstanding
76.74M
No. of employees
321
Open
NT$61.70
High
NT$61.90
Low
NT$60.80
Mkt. cap
5.26B
Avg. vol.
373.37K
Volume
262.15K
Dividend
3.26%
Quarterly dividend
NT$0.50
Ex-dividend date
Jun 11, 2026
P/E ratio
24.64
52-wk high
NT$82.00
52-wk low
NT$58.00
EPS
NT$2.49
Shares outstanding
76.74M
No. of employees
321
News stories
From sources across the web
About Panion & BF Biotech Inc
CEO-
Employees321
Founded1976
Headquarters-
SectorPharmaceutical industry
Websitepbf.com.tw
Previous reportsAll values in TWD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TWD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
503.77M
531.95M
546.14M
519.29M
Cost of goods sold
235.16M
231.66M
260.24M
249.91M
Cost of revenue
235.16M
231.66M
260.24M
249.91M
Research and development expenses
43.93M
45.90M
44.00M
41.03M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
145.56M
154.88M
168.49M
144.53M
Operating expense
189.26M
200.76M
213.55M
186.16M
Total operating expenses
424.42M
432.42M
473.79M
436.07M
Operating income
79.35M
99.52M
72.35M
83.22M
Other non operating income
330.00K
868.00K
2.88M
302.00K
EBT including unusual items
61.32M
104.58M
73.58M
80.60M
EBT excluding unusual items
60.93M
104.58M
73.49M
80.67M
Income tax expense
23.33M
29.23M
24.96M
28.86M
Effective tax rate
38.04%
27.95%
33.93%
35.80%
Other operating expenses
-
-
-
-
Net income
38.00M
75.35M
48.62M
51.74M
Net profit margin
7.54%
14.17%
8.90%
9.96%
Earnings per share
-
-
-
-
Interest and investment income
2.04M
349.00K
1.32M
146.00K
Interest expense
-3.60M
-3.60M
-3.47M
-3.45M
Net interest expenses
-1.57M
-3.25M
-2.15M
-3.31M
Depreciation and amortization charges
-
-
-
-
EBITDA
107.65M
127.81M
100.99M
112.84M
Gain or loss from assets sale
4.00K
-
125.00K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer